Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02159066
Title LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
Acronym LOGIC-2
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | GBR | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90024 United States Details
Cancer Care Center Los Angeles California 90095 United States Details
Doris Stein Research Center Building Los Angeles California 90095 United States Details
Ronald Reagan UCLA Medical Center Drug Information Center Department of Pharmaceutical Services Los Angeles California 90095 United States Details
UCLA Dermatology Clinic Los Angeles California 90095 United States Details
UCLA Oncology Center Los Angeles California 90095 United States Details
UCLA Radiology Los Angeles California 90095 United States Details
Memorial Sloan Kettering Cancer Center Attn: Geny O'neill New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center Inpatient Hospital & Main Campus New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center- Outpatient Clinic New York New York 10065 United States Details
OHSU Knight Cancer Institute Portland Oregon 97201 United States Details
OHSU Center for Health and Healing 2 Portland Oregon 97239 United States Details
OHSU Center for Health and Healing Portland Oregon 97239 United States Details
OHSU Research Pharmacy Services Portland Oregon 97239 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
East St Kilda Eye Clinic Melbourne Victoria 3183 Australia Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Sir Mortimer B. Davis-Jewish General Hospital Monteral Quebec H3T 1E2 Canada Details
University Clinic Heidelberg PPDS Heidelberg Baden-württemberg 69120 Germany Details
Universitätsklinikum Würzburg Würzburg Bayern 97080 Germany Details
Uniklinik Köln Köln 50937 Germany Details
Städtisches Klinikum München Muenchen 80337 Germany Details
Universitätsklinikum Würzburg Wuerzburg 97080 Germany Details
Azienda Ospedaliera Monaldi Napoli Campania 80131 Italy Details
U.O.C. Oncologia Medica e Terapie Innovative Dipartimento di Melanoma IRCCS Fondazione G. Pascale Napoli 80131 Italy Details
Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis Amsterdam 1066 CX Netherlands Details
Hospital Universitario Vall d'Hebrón - PPDS Barcelona Cataluna Barcelona 08035 Spain Details
Universitätsspital Zürich Zurich Flughafen 8058 Switzerland Details
Churchill Hospital Oxford OX2 7JL United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field